Newly detected atrial high rate episodes predict long-term mortality outcomes in patients with permanent pacemakers

Background Subclinical atrial high rate episodes (AHREs) detected by implanted devices in patients with no history of atrial fibrillation (AF) have been associated with an increased risk of stroke and systemic embolism. Data regarding the long-term survival of patients with permanent pacemakers and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Heart rhythm 2014-12, Vol.11 (12), p.2214-2221
Hauptverfasser: Gonzalez, Maday, MD, Keating, Richard J., MD, Markowitz, Steven M., MD, FHRS, Liu, Christopher F., MD, FHRS, Thomas, George, MD, Ip, James E., MD, FHRS, Lerman, Bruce B., MD, FHRS, Cheung, Jim W., MD, FHRS
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2221
container_issue 12
container_start_page 2214
container_title Heart rhythm
container_volume 11
creator Gonzalez, Maday, MD
Keating, Richard J., MD
Markowitz, Steven M., MD, FHRS
Liu, Christopher F., MD, FHRS
Thomas, George, MD
Ip, James E., MD, FHRS
Lerman, Bruce B., MD, FHRS
Cheung, Jim W., MD, FHRS
description Background Subclinical atrial high rate episodes (AHREs) detected by implanted devices in patients with no history of atrial fibrillation (AF) have been associated with an increased risk of stroke and systemic embolism. Data regarding the long-term survival of patients with permanent pacemakers and newly detected AHREs are limited. Objective This study aimed to assess whether newly detected AHREs in pacemaker patients predict mortality outcomes. Methods We evaluated 224 patients (mean age 74 ± 12 years; 118 men [53%]) with no history of AF who underwent dual-chamber pacemaker implantation from 2002 through 2004. During follow-up, patients with AHREs of ≥5-minute duration were identified. Mortality data were obtained from the National Death Index. Results Thirty-nine patients (17%) had AHREs of ≥5-minute duration within 6 months of pacemaker implantation. Over a mean follow-up period of 6.6 ± 2.0 years, the rate of all-cause mortality was 29%. In multivariate analysis adjusted for age, sex, and cardiovascular diseases, AHREs were associated with a significant increase in cardiovascular mortality (hazard ratio [HR] 2.80; 95% confidence interval [CI] 1.24–6.31; P = .013) and stroke mortality (HR 9.65; 95% CI 1.56–59.9; P = .015), with a trend toward increased all-cause mortality (HR 1.79; 95% CI 0.98–3.26; P = .059). The subgroup of patients with AHREs of ≥5-minute but
doi_str_mv 10.1016/j.hrthm.2014.08.019
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1629956244</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1547527114009023</els_id><sourcerecordid>1629956244</sourcerecordid><originalsourceid>FETCH-LOGICAL-c484t-ee7047094479da3be1f05e9e8cd9e968860294bd6a8b903a8ce5fc1629d60803</originalsourceid><addsrcrecordid>eNqFkU2P1SAUhonROB_6C0wMSzeth5ZSWGhiJjqaTHTh7AkXzp1ypy0VqJP776Xe0YUbV3zkeTmc5xDyikHNgIm3h3qIeZjqBhivQdbA1BNyzrpOVK3s2dNtz_uqa3p2Ri5SOgA0SkD7nJw1HWuZEP05SV_xYTxShxltRkdNjt6MdPB3A40mI8XFp-Aw0SWi8zbTMcx3VcY40SnEbEafjzSs2YapQH6mi8ke55zog88DXQpo5nIu9xYnc48xvSDP9mZM-PJxvSS3nz7eXn2ubr5df7n6cFNZLnmuEHvgPSjOe-VMu0O2hw4VSusUKiGlKP3wnRNG7hS0Rlrs9paJRjkBEtpL8ub07BLDjxVT1pNPFsex_CesSW-k6kTDeUHbE2pjSCniXi_RTyYeNQO9ydYH_Vu23mRrkLrILqnXjwXW3YTub-aP3QK8OwFYuvzpMepkixtbRMaiW7vg_1Pg_T95O_rZWzPe4xHTIaxxLgI106nRoL9v897GzTiAgqZtfwHrYah9</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1629956244</pqid></control><display><type>article</type><title>Newly detected atrial high rate episodes predict long-term mortality outcomes in patients with permanent pacemakers</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Gonzalez, Maday, MD ; Keating, Richard J., MD ; Markowitz, Steven M., MD, FHRS ; Liu, Christopher F., MD, FHRS ; Thomas, George, MD ; Ip, James E., MD, FHRS ; Lerman, Bruce B., MD, FHRS ; Cheung, Jim W., MD, FHRS</creator><creatorcontrib>Gonzalez, Maday, MD ; Keating, Richard J., MD ; Markowitz, Steven M., MD, FHRS ; Liu, Christopher F., MD, FHRS ; Thomas, George, MD ; Ip, James E., MD, FHRS ; Lerman, Bruce B., MD, FHRS ; Cheung, Jim W., MD, FHRS</creatorcontrib><description>Background Subclinical atrial high rate episodes (AHREs) detected by implanted devices in patients with no history of atrial fibrillation (AF) have been associated with an increased risk of stroke and systemic embolism. Data regarding the long-term survival of patients with permanent pacemakers and newly detected AHREs are limited. Objective This study aimed to assess whether newly detected AHREs in pacemaker patients predict mortality outcomes. Methods We evaluated 224 patients (mean age 74 ± 12 years; 118 men [53%]) with no history of AF who underwent dual-chamber pacemaker implantation from 2002 through 2004. During follow-up, patients with AHREs of ≥5-minute duration were identified. Mortality data were obtained from the National Death Index. Results Thirty-nine patients (17%) had AHREs of ≥5-minute duration within 6 months of pacemaker implantation. Over a mean follow-up period of 6.6 ± 2.0 years, the rate of all-cause mortality was 29%. In multivariate analysis adjusted for age, sex, and cardiovascular diseases, AHREs were associated with a significant increase in cardiovascular mortality (hazard ratio [HR] 2.80; 95% confidence interval [CI] 1.24–6.31; P = .013) and stroke mortality (HR 9.65; 95% CI 1.56–59.9; P = .015), with a trend toward increased all-cause mortality (HR 1.79; 95% CI 0.98–3.26; P = .059). The subgroup of patients with AHREs of ≥5-minute but &lt;1-day duration still had a significantly increased cardiovascular mortality (HR 3.24; 95% CI 1.37–7.66; P = .007). Conclusion AHREs are commonly encountered in pacemaker patients with no history of AF and are independent predictors of cardiovascular mortality.</description><identifier>ISSN: 1547-5271</identifier><identifier>EISSN: 1556-3871</identifier><identifier>DOI: 10.1016/j.hrthm.2014.08.019</identifier><identifier>PMID: 25131667</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aged ; Aged, 80 and over ; Analysis of Variance ; Atrial fibrillation ; Atrial Fibrillation - diagnosis ; Atrial Fibrillation - mortality ; Atrial Fibrillation - therapy ; Cardiac Pacing, Artificial - adverse effects ; Cardiac Pacing, Artificial - methods ; Cardiovascular ; Cause of Death ; Cohort Studies ; Electrocardiography - methods ; Embolism - etiology ; Embolism - mortality ; Embolism - physiopathology ; Female ; Follow-Up Studies ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Mortality ; Multivariate Analysis ; Pacemaker, Artificial ; Permanent pacemaker ; Predictive Value of Tests ; Retrospective Studies ; Risk Assessment ; Severity of Illness Index ; Stroke - etiology ; Stroke - mortality ; Stroke - physiopathology ; Survival Analysis ; Time Factors ; Treatment Outcome</subject><ispartof>Heart rhythm, 2014-12, Vol.11 (12), p.2214-2221</ispartof><rights>Heart Rhythm Society</rights><rights>2014 Heart Rhythm Society</rights><rights>Copyright © 2014 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c484t-ee7047094479da3be1f05e9e8cd9e968860294bd6a8b903a8ce5fc1629d60803</citedby><cites>FETCH-LOGICAL-c484t-ee7047094479da3be1f05e9e8cd9e968860294bd6a8b903a8ce5fc1629d60803</cites><orcidid>0000-0002-4403-1330</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1547527114009023$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25131667$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gonzalez, Maday, MD</creatorcontrib><creatorcontrib>Keating, Richard J., MD</creatorcontrib><creatorcontrib>Markowitz, Steven M., MD, FHRS</creatorcontrib><creatorcontrib>Liu, Christopher F., MD, FHRS</creatorcontrib><creatorcontrib>Thomas, George, MD</creatorcontrib><creatorcontrib>Ip, James E., MD, FHRS</creatorcontrib><creatorcontrib>Lerman, Bruce B., MD, FHRS</creatorcontrib><creatorcontrib>Cheung, Jim W., MD, FHRS</creatorcontrib><title>Newly detected atrial high rate episodes predict long-term mortality outcomes in patients with permanent pacemakers</title><title>Heart rhythm</title><addtitle>Heart Rhythm</addtitle><description>Background Subclinical atrial high rate episodes (AHREs) detected by implanted devices in patients with no history of atrial fibrillation (AF) have been associated with an increased risk of stroke and systemic embolism. Data regarding the long-term survival of patients with permanent pacemakers and newly detected AHREs are limited. Objective This study aimed to assess whether newly detected AHREs in pacemaker patients predict mortality outcomes. Methods We evaluated 224 patients (mean age 74 ± 12 years; 118 men [53%]) with no history of AF who underwent dual-chamber pacemaker implantation from 2002 through 2004. During follow-up, patients with AHREs of ≥5-minute duration were identified. Mortality data were obtained from the National Death Index. Results Thirty-nine patients (17%) had AHREs of ≥5-minute duration within 6 months of pacemaker implantation. Over a mean follow-up period of 6.6 ± 2.0 years, the rate of all-cause mortality was 29%. In multivariate analysis adjusted for age, sex, and cardiovascular diseases, AHREs were associated with a significant increase in cardiovascular mortality (hazard ratio [HR] 2.80; 95% confidence interval [CI] 1.24–6.31; P = .013) and stroke mortality (HR 9.65; 95% CI 1.56–59.9; P = .015), with a trend toward increased all-cause mortality (HR 1.79; 95% CI 0.98–3.26; P = .059). The subgroup of patients with AHREs of ≥5-minute but &lt;1-day duration still had a significantly increased cardiovascular mortality (HR 3.24; 95% CI 1.37–7.66; P = .007). Conclusion AHREs are commonly encountered in pacemaker patients with no history of AF and are independent predictors of cardiovascular mortality.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Analysis of Variance</subject><subject>Atrial fibrillation</subject><subject>Atrial Fibrillation - diagnosis</subject><subject>Atrial Fibrillation - mortality</subject><subject>Atrial Fibrillation - therapy</subject><subject>Cardiac Pacing, Artificial - adverse effects</subject><subject>Cardiac Pacing, Artificial - methods</subject><subject>Cardiovascular</subject><subject>Cause of Death</subject><subject>Cohort Studies</subject><subject>Electrocardiography - methods</subject><subject>Embolism - etiology</subject><subject>Embolism - mortality</subject><subject>Embolism - physiopathology</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Kaplan-Meier Estimate</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Multivariate Analysis</subject><subject>Pacemaker, Artificial</subject><subject>Permanent pacemaker</subject><subject>Predictive Value of Tests</subject><subject>Retrospective Studies</subject><subject>Risk Assessment</subject><subject>Severity of Illness Index</subject><subject>Stroke - etiology</subject><subject>Stroke - mortality</subject><subject>Stroke - physiopathology</subject><subject>Survival Analysis</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><issn>1547-5271</issn><issn>1556-3871</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU2P1SAUhonROB_6C0wMSzeth5ZSWGhiJjqaTHTh7AkXzp1ypy0VqJP776Xe0YUbV3zkeTmc5xDyikHNgIm3h3qIeZjqBhivQdbA1BNyzrpOVK3s2dNtz_uqa3p2Ri5SOgA0SkD7nJw1HWuZEP05SV_xYTxShxltRkdNjt6MdPB3A40mI8XFp-Aw0SWi8zbTMcx3VcY40SnEbEafjzSs2YapQH6mi8ke55zog88DXQpo5nIu9xYnc48xvSDP9mZM-PJxvSS3nz7eXn2ubr5df7n6cFNZLnmuEHvgPSjOe-VMu0O2hw4VSusUKiGlKP3wnRNG7hS0Rlrs9paJRjkBEtpL8ub07BLDjxVT1pNPFsex_CesSW-k6kTDeUHbE2pjSCniXi_RTyYeNQO9ydYH_Vu23mRrkLrILqnXjwXW3YTub-aP3QK8OwFYuvzpMepkixtbRMaiW7vg_1Pg_T95O_rZWzPe4xHTIaxxLgI106nRoL9v897GzTiAgqZtfwHrYah9</recordid><startdate>20141201</startdate><enddate>20141201</enddate><creator>Gonzalez, Maday, MD</creator><creator>Keating, Richard J., MD</creator><creator>Markowitz, Steven M., MD, FHRS</creator><creator>Liu, Christopher F., MD, FHRS</creator><creator>Thomas, George, MD</creator><creator>Ip, James E., MD, FHRS</creator><creator>Lerman, Bruce B., MD, FHRS</creator><creator>Cheung, Jim W., MD, FHRS</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-4403-1330</orcidid></search><sort><creationdate>20141201</creationdate><title>Newly detected atrial high rate episodes predict long-term mortality outcomes in patients with permanent pacemakers</title><author>Gonzalez, Maday, MD ; Keating, Richard J., MD ; Markowitz, Steven M., MD, FHRS ; Liu, Christopher F., MD, FHRS ; Thomas, George, MD ; Ip, James E., MD, FHRS ; Lerman, Bruce B., MD, FHRS ; Cheung, Jim W., MD, FHRS</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c484t-ee7047094479da3be1f05e9e8cd9e968860294bd6a8b903a8ce5fc1629d60803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Analysis of Variance</topic><topic>Atrial fibrillation</topic><topic>Atrial Fibrillation - diagnosis</topic><topic>Atrial Fibrillation - mortality</topic><topic>Atrial Fibrillation - therapy</topic><topic>Cardiac Pacing, Artificial - adverse effects</topic><topic>Cardiac Pacing, Artificial - methods</topic><topic>Cardiovascular</topic><topic>Cause of Death</topic><topic>Cohort Studies</topic><topic>Electrocardiography - methods</topic><topic>Embolism - etiology</topic><topic>Embolism - mortality</topic><topic>Embolism - physiopathology</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Kaplan-Meier Estimate</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Multivariate Analysis</topic><topic>Pacemaker, Artificial</topic><topic>Permanent pacemaker</topic><topic>Predictive Value of Tests</topic><topic>Retrospective Studies</topic><topic>Risk Assessment</topic><topic>Severity of Illness Index</topic><topic>Stroke - etiology</topic><topic>Stroke - mortality</topic><topic>Stroke - physiopathology</topic><topic>Survival Analysis</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gonzalez, Maday, MD</creatorcontrib><creatorcontrib>Keating, Richard J., MD</creatorcontrib><creatorcontrib>Markowitz, Steven M., MD, FHRS</creatorcontrib><creatorcontrib>Liu, Christopher F., MD, FHRS</creatorcontrib><creatorcontrib>Thomas, George, MD</creatorcontrib><creatorcontrib>Ip, James E., MD, FHRS</creatorcontrib><creatorcontrib>Lerman, Bruce B., MD, FHRS</creatorcontrib><creatorcontrib>Cheung, Jim W., MD, FHRS</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Heart rhythm</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gonzalez, Maday, MD</au><au>Keating, Richard J., MD</au><au>Markowitz, Steven M., MD, FHRS</au><au>Liu, Christopher F., MD, FHRS</au><au>Thomas, George, MD</au><au>Ip, James E., MD, FHRS</au><au>Lerman, Bruce B., MD, FHRS</au><au>Cheung, Jim W., MD, FHRS</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Newly detected atrial high rate episodes predict long-term mortality outcomes in patients with permanent pacemakers</atitle><jtitle>Heart rhythm</jtitle><addtitle>Heart Rhythm</addtitle><date>2014-12-01</date><risdate>2014</risdate><volume>11</volume><issue>12</issue><spage>2214</spage><epage>2221</epage><pages>2214-2221</pages><issn>1547-5271</issn><eissn>1556-3871</eissn><abstract>Background Subclinical atrial high rate episodes (AHREs) detected by implanted devices in patients with no history of atrial fibrillation (AF) have been associated with an increased risk of stroke and systemic embolism. Data regarding the long-term survival of patients with permanent pacemakers and newly detected AHREs are limited. Objective This study aimed to assess whether newly detected AHREs in pacemaker patients predict mortality outcomes. Methods We evaluated 224 patients (mean age 74 ± 12 years; 118 men [53%]) with no history of AF who underwent dual-chamber pacemaker implantation from 2002 through 2004. During follow-up, patients with AHREs of ≥5-minute duration were identified. Mortality data were obtained from the National Death Index. Results Thirty-nine patients (17%) had AHREs of ≥5-minute duration within 6 months of pacemaker implantation. Over a mean follow-up period of 6.6 ± 2.0 years, the rate of all-cause mortality was 29%. In multivariate analysis adjusted for age, sex, and cardiovascular diseases, AHREs were associated with a significant increase in cardiovascular mortality (hazard ratio [HR] 2.80; 95% confidence interval [CI] 1.24–6.31; P = .013) and stroke mortality (HR 9.65; 95% CI 1.56–59.9; P = .015), with a trend toward increased all-cause mortality (HR 1.79; 95% CI 0.98–3.26; P = .059). The subgroup of patients with AHREs of ≥5-minute but &lt;1-day duration still had a significantly increased cardiovascular mortality (HR 3.24; 95% CI 1.37–7.66; P = .007). Conclusion AHREs are commonly encountered in pacemaker patients with no history of AF and are independent predictors of cardiovascular mortality.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>25131667</pmid><doi>10.1016/j.hrthm.2014.08.019</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-4403-1330</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1547-5271
ispartof Heart rhythm, 2014-12, Vol.11 (12), p.2214-2221
issn 1547-5271
1556-3871
language eng
recordid cdi_proquest_miscellaneous_1629956244
source MEDLINE; Elsevier ScienceDirect Journals
subjects Aged
Aged, 80 and over
Analysis of Variance
Atrial fibrillation
Atrial Fibrillation - diagnosis
Atrial Fibrillation - mortality
Atrial Fibrillation - therapy
Cardiac Pacing, Artificial - adverse effects
Cardiac Pacing, Artificial - methods
Cardiovascular
Cause of Death
Cohort Studies
Electrocardiography - methods
Embolism - etiology
Embolism - mortality
Embolism - physiopathology
Female
Follow-Up Studies
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Mortality
Multivariate Analysis
Pacemaker, Artificial
Permanent pacemaker
Predictive Value of Tests
Retrospective Studies
Risk Assessment
Severity of Illness Index
Stroke - etiology
Stroke - mortality
Stroke - physiopathology
Survival Analysis
Time Factors
Treatment Outcome
title Newly detected atrial high rate episodes predict long-term mortality outcomes in patients with permanent pacemakers
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T00%3A47%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Newly%20detected%20atrial%20high%20rate%20episodes%20predict%20long-term%20mortality%20outcomes%20in%20patients%20with%20permanent%20pacemakers&rft.jtitle=Heart%20rhythm&rft.au=Gonzalez,%20Maday,%20MD&rft.date=2014-12-01&rft.volume=11&rft.issue=12&rft.spage=2214&rft.epage=2221&rft.pages=2214-2221&rft.issn=1547-5271&rft.eissn=1556-3871&rft_id=info:doi/10.1016/j.hrthm.2014.08.019&rft_dat=%3Cproquest_cross%3E1629956244%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1629956244&rft_id=info:pmid/25131667&rft_els_id=S1547527114009023&rfr_iscdi=true